                         SEQUENCE LISTING

<110>  The Regents of the University of California
 
<120>  Synthetic Platelets

<130>  UCSB011PCT2

<150>  61/935,297
<151>  2014-02-03

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (18)..(18)
<223>  Xaa is hydroxyproline

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  Xaa is hydroxyproline

<400>  1

Gly Pro Xaa Gly Pro Xaa Gly Pro Xaa Gly Pro Xaa Gly Pro Xaa Gly 
1               5                   10                  15      


Pro Xaa Gly Pro Xaa 
            20      


<210>  2
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  2

Thr Arg Tyr Leu Arg Ile His Pro Gln Ser Trp Val His Gln Ile 
1               5                   10                  15  


<210>  3
<211>  5
<212>  PRT
<213>  Homo sapiens

<400>  3

Gly Arg Gly Asp Ser 
1               5   


<210>  4
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  4

Tyr Met Glu Ser Arg Ala Asp Arg 
1               5               


<210>  5
<211>  17
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<400>  5

Arg Met Ala Pro Glu Glu Glu Met Asp Arg Pro Phe Leu Tyr Val Val 
1               5                   10                  15      


Arg 
    


<210>  6
<211>  7
<212>  PRT
<213>  Rana spp.


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  The terminal K residue may be deleted

<400>  6

Arg Val Arg Ser Phe Tyr Lys 
1               5           


